AtriCure, Inc. ATRC
NASDAQ
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 0.55% | 8.75% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.55% | 8.75% | |||
| Cost of Revenue | 0.36% | 9.51% | |||
| Gross Profit | 0.61% | 8.52% | |||
| SG&A Expenses | 0.39% | -2.35% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.28% | 2.29% | |||
| Operating Income | -54.96% | 1,737.45% | |||
| Income Before Tax | -57.38% | 2,292.39% | |||
| Income Tax Expenses | -109.98% | 64.69% | |||
| Earnings from Continuing Operations | -54.62% | 8,191.67% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -54.62% | 8,191.67% | |||
| EBIT | -54.96% | 1,737.45% | |||
| EBITDA | -34.36% | 158.18% | |||
| EPS Basic | -54.84% | 8,263.64% | |||
| Normalized Basic EPS | -57.64% | 2,274.51% | |||
| EPS Diluted | -55.56% | 8,081.82% | |||
| Normalized Diluted EPS | -58.21% | 2,312.00% | |||
| Average Basic Shares Outstanding | 0.46% | 0.69% | |||
| Average Diluted Shares Outstanding | 1.97% | -0.36% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||